跳至主要内容
临床试验/NCT03540186
NCT03540186Unknown不适用

A Nutritional Supplement Epigenome Antivir Combined With Acupuncture for the Treatment of Osteoarthritis Who Are Overweight or Obese

Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2018年6月29日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
15
试验地点
1
主要终点
Change From Baseline in Visual Analogue Scale for Pain

研究概览

简要总结

The study evaluates analgesic, antiinflammatory and metabolic effects of a supplement Epigenome-Antivir (extracts of glycyrrhiza roots, hippophae rhamnoides leaves, curcumin, green tea, and vitamin C) combined with acupuncture in patients with knee osteoarthritis (OA) and metabolic syndrome.

详细描述

Epigenome-Antivir components have long been used in traditional medicine and have been shown to exert anti-inflammatory properties both in vitro and in vivo. It has also been shown that acupuncture can provide a moderate analgesic effect in osteoarthritis. It is anticipated that the combination of Epigenome-Antivir and acupuncture will reduce pain, inflammatory and metabolic markers in patients with OA and metabolic syndrome.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •osteoarthritis of the knee fulfilling American College of Rheumatology (ACR) criteria
  • •BMI of 25 or more

排除标准

  • •use of NSAIDs one month prior to study entry (paracetamol is allowed)
  • •pregnancy and lactation
  • •increased sensitivity to the study drug
  • •clinically significant renal function impairment
  • •use of antidepressants
  • •diagnosis of bipolar disorder
  • •use of symptomatic slow acting drugs of OA (SYSADOA) one month prior to study entry
  • •any condition which may lead to difficulties to participation in the study from the viewpoint of Investigator

研究组 & 干预措施

Epigenorm Antivir and acupuncture arm

Experimental

Epigenorm Antivir is a dietary supplement containing extracts of glycyrrhiza roots, hippophae rhamnoides leaves, curcumin, green tea, and vitamin C. Acupuncture involves inserting needles at certain points of the body.

干预措施: Epigenorm Antivir (Dietary Supplement)

Epigenorm Antivir and acupuncture arm

Experimental

Epigenorm Antivir is a dietary supplement containing extracts of glycyrrhiza roots, hippophae rhamnoides leaves, curcumin, green tea, and vitamin C. Acupuncture involves inserting needles at certain points of the body.

干预措施: Acupuncture (Procedure)

结局指标

主要结局

Change From Baseline in Visual Analogue Scale for Pain

时间窗: Baseline, 4 weeks, 8 weeks, 12 weeks

The Visual Analogue Scale for Pain varies from 0 to 10 cm. Higher values represent worse outcomes.

次要结局

  • Knee injury and Osteoarthritis Outcome Score (KOOS) - subscale Symptoms(Baseline, 4 weeks, 8 weeks, 12 weeks)
  • Quality of life with the The Short Form (36) Health Survey score(Baseline, 4 weeks, 8 weeks, 12 weeks)
  • Changes in serum levels of aggrecan(Baseline, 8 weeks)
  • Intermittent and Constant Osteoarthritis Pain self-report questionnaire(Baseline, 4 weeks, 8 weeks, 12 weeks)
  • Knee injury and Osteoarthritis Outcome Score (KOOS) - subscale Activities of daily living (ADL)(Baseline, 4 weeks, 8 weeks, 12 weeks)
  • Changes in serum levels of C-reactive protein(Baseline, 8 weeks)
  • Knee injury and Osteoarthritis Outcome Score (KOOS) - subscale Pain(Baseline, 4 weeks, 8 weeks, 12 weeks)
  • Changes in serum levels of antibodies to collagen type II(Baseline, 8 weeks)
  • Changes in histamine levels(Baseline, 8 weeks)
  • Changes in inflammation biomarkers(Baseline, 8 weeks)
  • Changes in lipid biomarkers(Baseline, 8 weeks)
  • Changes in depression scores measured with Patient Health Questionnaire-9 (PHQ9P)(Baseline, 4 weeks, 8 weeks, 12 weeks)

研究者

发起方
Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ivan Shirinsky, MD, PhD

Principal Investigator

Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology

研究点 (1)

Loading locations...

相似试验